Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
Top Cited Papers
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9230) , 615-620
- https://doi.org/10.1016/s0140-6736(00)02602-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Bradykinin-Mediated Cardiovascular Protective Actions of ACE InhibitorsDrugs, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of studies of left ventricular dysfunctionJournal of the American College of Cardiology, 1994
- Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.Hypertension, 1994
- Atrial and brain natriuretic peptides in cardiovascular diseases.Hypertension, 1994
- Activation of neurohumoral systems in postinfarction left ventricular dysfunctionJournal of the American College of Cardiology, 1993
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989